Long-acting GLP-1 receptor agonist for metabolic research. Weekly dosing analog with extended half-life via fatty acid conjugation.
Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist with 94% sequence homology to native human GLP-1. It features a C18 fatty acid chain enabling albumin binding and extended half-life (~7 days). Originally developed for type 2 diabetes, it has become one of the most extensively researched peptides for metabolic regulation.
Manufactured via solid-phase peptide synthesis (SPPS) with rigorous quality controls. Each batch undergoes HPLC, LC-MS, endotoxin (LAL), and residual solvent testing with full Certificate of Analysis provided.
| Product Name | Semaglutide |
| CAS Number | 910463-68-2 |
| Purity | ≥98% (by HPLC) |
| Molecular Weight | 4,113.58 g/mol |
| Molecular Formula | C₁₈₇H₂₉₁N₄₅O₅₉ |
| Appearance | White to off-white lyophilized powder |
| Storage | Store at -20°C desiccated. Stable for 24 months. Reconstituted: use within 7 days at 2-8°C. |
| Available Sizes | 3 mg · 5 mg · 10 mg · 50 mg · 100 mg · Custom |
Store at -20°C desiccated. Stable for 24 months. Reconstituted: use within 7 days at 2-8°C.
24 months from manufacture when stored properly.
Cold-chain shipping with ice packs. Express delivery to 35+ countries.
Get premium research-grade peptides with complete documentation and worldwide delivery.